跳至主要内容
临床试验/NCT04724603
NCT04724603招募中不适用

Phage Safety Retrospective Cohort Study

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
25
试验地点
1
主要终点
rate of patients having had an adverse event

研究概览

简要总结

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event

排除标准

  • 未提供

结局指标

主要结局

rate of patients having had an adverse event

时间窗: 1 year

number of patients having had an adverse event

rate of adverse event attributable to the surgery

时间窗: 1 year

number of patients having had an adverse event because of the surgery

type of adverse event attributable to the surgery

时间窗: 1 year

classification according to Clavien's Clasification

rate of adverse event attributable to the antibiotic treatment

时间窗: 1 year

number of patients having had an adverse event because of the antibiotic treatment

rate of adverse event attributable to the phagotherapy

时间窗: 1 year

number of patients having had an adverse event because of phagotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验